These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16393909)

  • 1. Ketorolac tromethamine liposomes: encapsulation and release studies.
    Ruozi B; Tosi G; Forni F; Angela Vandelli M
    J Liposome Res; 2005; 15(3-4):175-85. PubMed ID: 16393909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres as a depot system for parenteral delivery.
    Sinha VR; Trehan A
    Drug Deliv; 2008 Aug; 15(6):365-72. PubMed ID: 18686080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
    Mathew ST; Devi SG; KV S
    AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
    Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPTLC determination of ketorolac tromethamine.
    Devarajan PV; Gore SP; Chavan SV
    J Pharm Biomed Anal; 2000 May; 22(4):679-83. PubMed ID: 10768358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR; Trehan A
    Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and pharmacokinetics of ketorolac tromethamine fast dissolving tablets.
    Mettu SR; Veerareddy PR
    Drug Res (Stuttg); 2013 Nov; 63(11):586-90. PubMed ID: 23780501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
    Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
    Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization of drug-loaded rigid and elastic vesicles.
    Uchino T; Lefeber F; Gooris G; Bouwstra J
    Int J Pharm; 2011 Jun; 412(1-2):142-7. PubMed ID: 21540095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
    Waterbury LD; Silliman D; Jolas T
    Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of freezing, long-term storage, and microwave thawing on the stability of ketorolac tromethamine.
    Hecq JD; Boitquin LP; Vanbeckbergen DF; Jamart J; Galanti LM
    Ann Pharmacother; 2005 Oct; 39(10):1654-8. PubMed ID: 16159993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
    Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
    J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable microspheres of ketorolac tromethamine for parenteral administration.
    Bhaskaran S; Suresh S
    J Microencapsul; 2004 Nov; 21(7):743-50. PubMed ID: 15799224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, development and characterization of ketorolac tromethamine polymeric nanosuspension.
    Jadhav PA; Yadav AV
    Ther Deliv; 2019 Sep; 10(9):585-597. PubMed ID: 31581882
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposome-oligonucleotides interaction for in vitro uptake by COS I and HaCaT cells.
    Ruozi B; Battini R; Tosi G; Forni F; Vandelli MA
    J Drug Target; 2005 Jun; 13(5):295-304. PubMed ID: 16199373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of calcitonin in liposomes depends on the vesicle preparation method.
    Arien A; Dupuy B
    J Microencapsul; 1997; 14(6):753-60. PubMed ID: 9394256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Erythrodiol, A Natural Pentacyclic Triterpene from Olive Oil, on the Lipid Membrane Properties.
    Habib L; Jraij A; Khreich N; Charcosset C; Greige-Gerges H
    J Membr Biol; 2015 Dec; 248(6):1079-87. PubMed ID: 26141679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lysine clonixinate and ketorolac tromethamine on prostanoid release from various rat organs incubated ex vivo.
    Pallapies D; Salinger A; Meyer zum Gottesberge A; Atkins DJ; Rohleder G; Nagyiványi P; Peskar BA
    Life Sci; 1995; 57(2):83-9. PubMed ID: 7603299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.